Daewon Pharmaceutical Co., Ltd. (003220.KS)

KRW 14020.0

(-1.2%)

Total Debt Summary of Daewon Pharmaceutical Co., Ltd.

  • Daewon Pharmaceutical Co., Ltd.'s latest annual total debt in 2023 was 146.04 Billion KRW , up 25.39% from previous year.
  • Daewon Pharmaceutical Co., Ltd.'s latest quarterly total debt in 2024 Q1 was 163.92 Billion KRW , up 12.24% from previous quarter.
  • Daewon Pharmaceutical Co., Ltd. reported annual total debt of 116.47 Billion KRW in 2022, down -6.04% from previous year.
  • Daewon Pharmaceutical Co., Ltd. reported annual total debt of 123.96 Billion KRW in 2021, up 136.23% from previous year.
  • Daewon Pharmaceutical Co., Ltd. reported quarterly total debt of 191.3 Billion KRW for 2024 Q2, up 16.7% from previous quarter.
  • Daewon Pharmaceutical Co., Ltd. reported quarterly total debt of 114.2 Billion KRW for 2023 Q2, up 0.14% from previous quarter.

Annual Total Debt Chart of Daewon Pharmaceutical Co., Ltd. (2023 - 2007)

Historical Annual Total Debt of Daewon Pharmaceutical Co., Ltd. (2023 - 2007)

Year Total Debt Total Debt Growth
2023 146.04 Billion KRW 25.39%
2022 116.47 Billion KRW -6.04%
2021 123.96 Billion KRW 136.23%
2020 52.47 Billion KRW 2.57%
2019 51.16 Billion KRW 82.73%
2018 28 Billion KRW 180.0%
2017 10 Billion KRW 0.0%
2016 - KRW 0.0%
2015 - KRW -100.0%
2014 3 Billion KRW 0.0%
2013 3 Billion KRW 0.0%
2012 3 Billion KRW -51.61%
2011 6.2 Billion KRW 3.33%
2010 6 Billion KRW -49.03%
2009 11.77 Billion KRW 142.0%
2008 4.86 Billion KRW -3.81%
2007 5.05 Billion KRW 0.0%

Peer Total Debt Comparison of Daewon Pharmaceutical Co., Ltd.

Name Total Debt Total Debt Difference
Dongwha Pharm.Co.,Ltd 48.25 Billion KRW -202.66%
Yuhan Corporation 230.07 Billion KRW 36.52%
Yuhan Corporation 230.07 Billion KRW 36.52%
Yuyu Pharma, Inc. 39.4 Billion KRW -270.617%
Yuyu Pharma, Inc. 39.4 Billion KRW -270.617%
Yuyu Pharma, Inc. 39.4 Billion KRW -270.617%
Ildong Holdings Co., Ltd. 382.06 Billion KRW 61.773%
Samil Pharmaceutical Co.,Ltd 175.87 Billion KRW 16.96%
Dong-A Socio Holdings Co., Ltd. 691.88 Billion KRW 78.891%
JW Pharmaceutical Corporation 170.28 Billion KRW 14.23%
JW Pharmaceutical Corporation 170.28 Billion KRW 14.23%
JW Pharmaceutical Corporation 170.28 Billion KRW 14.23%
SAMSUNG PHARM. Co., LTD. 595.48 Million KRW -24426.145%
Chong Kun Dang Holdings Corp. 468.03 Billion KRW 68.795%
Dong Sung Bio Pharm.Co.,Ltd. 43.27 Billion KRW -237.509%
HANDOK Inc. 300.01 Billion KRW 51.319%
Jeil Pharma Holdings Inc 173.03 Billion KRW 15.593%
Kukje Pharma Co., Ltd. 30.66 Billion KRW -376.32%
Bukwang Pharmaceutical Co., Ltd. 79.38 Billion KRW -83.972%
Aprogen pharmaceuticals,Inc. 180.99 Billion KRW 19.308%
Ilsung Pharmaceuticals Co., Ltd. 238.12 Million KRW -61232.949%
Yungjin Pharm. Co., Ltd. 66.88 Billion KRW -118.369%
Boryung Corporation 204.21 Billion KRW 28.483%
Hyundai Pharmaceutical Co., Ltd. 39.2 Billion KRW -272.529%
Samjin Pharmaceuticals Co., Ltd. 118.63 Billion KRW -23.105%
Ilyang Pharmaceutical Co.,Ltd 85.15 Billion KRW -71.501%
Ilyang Pharmaceutical Co.,Ltd 85.15 Billion KRW -71.501%
Suheung Co., Ltd. 467.85 Billion KRW 68.783%
Kwang Dong Pharmaceutical Co., Ltd. 235.64 Billion KRW 38.02%
Hanall Biopharma Co.,Ltd 1.29 Billion KRW -11217.035%
Whan In Pharm Co.,Ltd. 632.02 Million KRW -23008.196%
MYUNGMOON Pharm co.,Ltd 90.48 Billion KRW -61.413%
Shin Poong Pharm.Co.,Ltd. 46.15 Billion KRW -216.458%
Shin Poong Pharm.Co.,Ltd. 46.15 Billion KRW -216.458%
Korea United Pharm Inc. 40.33 Billion KRW -262.056%
CKD Bio Corp. 146.92 Billion KRW 0.597%
Daewoong pharmaceutical Co.,Ltd 469.68 Billion KRW 68.905%
JW Holdings Corporation 554.58 Billion KRW 73.665%
REYON Pharmaceutical Co., Ltd. 225.05 Billion KRW 35.105%
Hanmi Pharm. Co., Ltd. 572.86 Billion KRW 74.505%
Dong-A ST Co., Ltd. 406.7 Billion KRW 64.09%
Chong Kun Dang Pharmaceutical Corp. 219.76 Billion KRW 33.542%
JW Lifescience Corporation 46.31 Billion KRW -215.355%
Ildong Pharmaceutical Co., Ltd. 217.84 Billion KRW 32.956%
Jeil Pharmaceutical Co.,Ltd 84.96 Billion KRW -71.893%
Hana Pharm Co., Ltd. 26.53 Billion KRW -450.444%